ISRG
Intuitive Surgical Inc.
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Best Orthopedic Devices Stocks 2026 →
Intuitive Surgical (ISRG) Stock: Buy, Sell, or Hold?
$443.59
+3.70 (+0.84%)
â˛
5d:
-2.03%
30d:
+3.68%
90d:
+13.64%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 20, 2026
0d
Protect ISRG Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (45%)
Quality Score
39/100
Position
FAIR
30-Day Fair Range
$420.43 â $455.05
Position: FAIR
Forward P/E & Valuation
35.6x
CHEAP
vs 40.0x historical avg
Wall Street Target
$486.57
+9.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$434.05 / $485.85
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: ISRG is fairly priced but lacks strong directional signals. At -3.8% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 6, 2026 at $457.44 · last confirmed Nov 10, 2026
Strength: 4.5/10
Get Alerted When ISRG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$444.88
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$276.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ISRG is currently trading at $443.59, which is considered fair relative to its 30-day fair value range of $420.43 to $455.05. From a valuation perspective, the stock is trading at a discount (Forward PE: 35.6) compared to its historical average (40.0). Remarkably, the market is currently pricing in an annual earnings decline of 3.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ISRG is in a strong downtrend. The price is currently testing key support at $434.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ISRG scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ISRG is in a strong downtrend. The price is currently testing key support at $434.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ISRG scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$420.43 -
$455.05
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
45.2%
Trading Range & Key Levels
30-Day Trading Range
$420.43 -
$455.05
Current vs Trading Range
FAIR
Support Level
$434.05
Resistance Level
$485.85
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding ISRG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (34/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($486.57)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
35.58
Wall Street Target
$486.57
(+9.7%)
Revenue Growth (YoY)
21.7%
Earnings Growth (YoY)
-23.6%
Profit Margin
25.5%
Valuation Discount vs History
-3.8% cheaper
PE vs Historical
35.6 vs 40.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.8%
(market-implied from PE analysis)
1-Year Target
$426.73
(-4%)
2-Year Target
$410.52
(-8%)
3-Year Target
$394.92
(-11%)
3-Yr Target (if PE normalizes)
(PE: 36â40)
$444.03
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 35.6, Growth: 10.8%)
$603.53
(+36%)
Base:
(SPY PE: 19.9, Growth: 10.8%)
$336.91
(-24%)
Bear:
(PE: 16.9, Growth: 10.8%)
$286.38
(-35%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (36x PE) as earnings recover.
Forward PE: 35.97 | Forward EPS (Implied): $12.33
Bull Case
$535.63
(+21%)
Analyst growth 15.0%, PE expands to 37.8
Base Case
$443.59
(0%)
Market implied 0.0%, PE stable at 36.0
Bear Case
$339.35
(-24%)
Severe decline -15.0%, PE contracts to 32.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 35.6 to 40.0
Stabilization Target:
$498.75
(+12.4%)
PE Expansion Potential:
+12.4%
Share ISRG Analysis
Share this live ISRG analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ISRG)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
BrightSpring Health Services (BTSG) has shown strong growth in its Specialty and Infusion business, driving a 34% YoY increase in revenues to $3.18 billion in Q3 2026. The company's shares have rallied 86.5% YTD, with a forward P/E ratio of 38.75.
Key Retail Themes:
Strong growth in Specialty and Infusion business
Expanding pharma services and hub programs
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 5:46 AM ET
Data refreshes hourly during market hours. Next update: 6:46 AM
Data refreshes hourly during market hours. Next update: 6:46 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ISRG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 36 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 37 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
16 analysts |
$471 | 46 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 63 BUY |
|
MMSI
Merit Medical Systems Inc |
STRONG BUY
12 analysts |
$107 | 60 BUY |
Advanced ISRG Option Strategies
Professional options setups generated by AI based on today's ISRG price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ISRG Research Pages
